(P-2030) Remdesivir and Obeldesivir Retain Potent Activity Against SARS-CoV-2 Omicron Variants

Saturday, October 19, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Lauren Rodriguez, PhD

Research Scientist
Gilead Sciences, Inc.
Foster City, CA, United States

JR

J. Lizbeth Reyes Zamora, PhD

Gilead Sciences, Inc.
Foster City, California, United States
DH

Dong Han, MS

Gilead Sciences, Inc.
Foster City, California, United States
NP

Nadine Peinovich, MPH

Gilead Sciences, Inc.
Foster City, California, United States
CM

Clarissa Martinez, MPH

Gilead Sciences, Inc.
Foster City, California, United States
PH

Pui Yan Ho, PhD

Gilead Sciences, Inc.
Foster City, California, United States
JL

Jiani Li, PhD

Gilead Sciences, Inc.
Foster City, California, United States
TA

Thomas Aeschbacher, PhD

Gilead Sciences, Inc.
Foster City, California, United States
AP

Andy Pekosz, PhD

Professor
Johns Hopkins University
Baltimore, Maryland, United States
JB

John P. Bilello, PhD

Gilead Sciences, Inc.
Foster City, California, United States
JP

Jason K. Perry, PhD

Gilead Sciences, Inc.
Foster City, California, United States
Charlotte Hedskog, PhD (she/her/hers)

Senior Research Scientist
Gilead Sciences, Inc.
Foster City, California, United States